Your browser doesn't support javascript.
loading
Altered Caveolin-1 Dynamics Result in Divergent Mineralization Responses in Bone and Vascular Calcification.
Bakhshian Nik, Amirala; Kaiser, Katherine; Sun, Patrick; Khomtchouk, Bohdan B; Hutcheson, Joshua D.
  • Bakhshian Nik A; Department of Biomedical Engineering, Florida International University, 10555 W Flagler St, EC 2612, Miami, FL 33174 USA.
  • Kaiser K; Department of Biomedical Engineering, Florida International University, 10555 W Flagler St, EC 2612, Miami, FL 33174 USA.
  • Sun P; Department of BioHealth Informatics, Luddy School of Informatics, Computing, and Engineering, Indiana University, 535 W Michigan St, IT 477, Indianapolis, IN 46202 USA.
  • Khomtchouk BB; Department of BioHealth Informatics, Luddy School of Informatics, Computing, and Engineering, Indiana University, 535 W Michigan St, IT 477, Indianapolis, IN 46202 USA.
  • Hutcheson JD; Krannert Cardiovascular Research Center, Indiana University School of Medicine, Indianapolis, IN USA.
Cell Mol Bioeng ; 16(4): 299-308, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37811003
ABSTRACT

Introduction:

Though vascular smooth muscle cells adopt an osteogenic phenotype during pathological vascular calcification, clinical studies note an inverse correlation between bone mineral density and arterial mineral-also known as the calcification paradox. Both processes are mediated by extracellular vesicles (EVs) that sequester calcium and phosphate. Calcifying EV formation in the vasculature requires caveolin-1 (CAV1), a membrane scaffolding protein that resides in membrane invaginations (caveolae). Of note, caveolin-1-deficient mice, however, have increased bone mineral density. We hypothesized that caveolin-1 may play divergent roles in calcifying EV formation from vascular smooth muscle cells (VSMCs) and osteoblasts (HOBs).

Methods:

Primary human coronary artery VSMCs and osteoblasts were cultured for up to 28 days in an osteogenic media. CAV1 expression was knocked down using siRNA. Methyl ß-cyclodextrin (MßCD) and a calpain inhibitor were used, respectively, to disrupt and stabilize the caveolar domains in VSMCs and HOBs.

Results:

CAV1 genetic variation demonstrates significant inverse relationships between bone-mineral density (BMD) and coronary artery calcification (CAC) across two independent epidemiological cohorts. Culture in osteogenic (OS) media increased calcification in HOBs and VSMCs. siRNA knockdown of CAV1 abrogated VSMC calcification with no effect on osteoblast mineralization. MßCD-mediated caveolae disruption led to a 3-fold increase of calcification in VSMCs treated with osteogenic media (p < 0.05) but hindered osteoblast mineralization (p < 0.01). Conversely, stabilizing caveolae by calpain inhibition prevented VSMC calcification (p < 0.05) without affecting osteoblast mineralization. There was no significant difference in CAV1 content between lipid domains from HOBs cultured in OS and control media.

Conclusion:

Our data indicate fundamental cellular-level differences in physiological and pathophysiological mineralization mediated by CAV1 dynamics. This is the first study to suggest that divergent mechanisms in calcifying EV formation may play a role in the calcification paradox. Supplementary Information The online version contains supplementary material available at 10.1007/s12195-023-00779-7.
Palabras clave